ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,180.74
1.03%
US Tech 100
17,573.60
0.89%
다우존스 지수
38,852.27
0.46%
Bitcoin
63,088.74
-1.42%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Pliant Therapeutics Inc (PLRX)

  7. Pliant Therapeutics Inc (PLRX) 뉴스

PLRX Pliant Therapeutics Inc

13.81
-0.17 (-1.22%)
최종 업데이트: 04:51:09
15분 지연
기업명 주식 심볼 시장 주식 타입
Pliant Therapeutics Inc PLRX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
-0.17 -1.22% 13.81 04:51:09
개장가 저가 고가 종가 전일 종가
14.09 13.71 14.33 13.98
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
06/05/202419:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/05/202421:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
02/04/202421:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
27/03/202423:23GLOBEPliant Therapeutics Announces Upcoming Presentations at the..
12/03/202420:30GLOBEPliant Therapeutics Announces Accelerated Bexotegrast..
28/02/202406:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
28/02/202406:06EDGAR2Form 8-K - Current report
28/02/202406:03GLOBEPliant Therapeutics Provides Corporate Update and Reports..
26/02/202422:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
15/02/202410:55EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/02/202422:52EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/02/202422:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
05/02/202421:31EDGAR2Form 8-K - Current report
05/02/202405:29GLOBEPliant Therapeutics Announces Positive Safety and..
25/01/202406:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/01/202406:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/01/202406:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/01/202406:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/01/202407:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/01/202407:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/01/202407:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/01/202422:00GLOBEPliant Therapeutics to Participate in the 42nd Annual J.P...
14/11/202306:30GLOBEPliant Therapeutics Presentations at The Liver Meeting® 2023..
10/11/202306:11EDGAR2Form 8-K - Current report
10/11/202306:05GLOBEPliant Therapeutics Provides Corporate Update and Reports..
08/11/202322:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
06/11/202322:00GLOBEPliant Therapeutics Presentations at the Annual Meeting of..
01/11/202305:03GLOBEPliant Therapeutics Announces Three Presentations at the..
19/10/202321:00GLOBEPliant Therapeutics INTEGRIS-PSC Phase 2a Interim Data..
17/10/202305:05GLOBEPliant Therapeutics Appoints S. Mishima Gerhart as Chief..
04/10/202305:53EDGAR2Form 8-K - Current report
26/09/202320:34EDGAR2Form 8-K - Current report
26/09/202320:30GLOBEPliant Therapeutics Announces Positive Safety and..
26/09/202305:05GLOBEPliant Therapeutics to Host Investor Call and Webcast to..
15/09/202321:00GLOBEPliant Therapeutics Appoints Minnie Kuo as Chief Development..
11/09/202321:00GLOBEPliant Therapeutics Announces Presentations at the European..
30/08/202321:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
29/08/202305:05GLOBEPliant Therapeutics Announces Three Upcoming Presentations..
10/08/202305:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/08/202305:05EDGAR2Form 8-K - Current report
10/08/202305:03GLOBEPliant Therapeutics Provides Corporate Update and Reports..
09/08/202321:00GLOBEPliant Therapeutics Announces Initiation of BEACON-IPF, a..
25/07/202321:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
22/07/202305:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/07/202305:06EDGAR2Form 144 - Report of proposed sale of securities
20/07/202309:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/07/202309:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/07/202309:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/07/202308:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/07/202308:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..

최근 히스토리

NASDAQ
PLRX
Pliant Therapeutics
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유